Defence Therapeutics Inc.: Defence Therapeutics Cancer Vaccine AccuVac-D001 Manufacturing Targets Melanoma and Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - November 23, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a biotechnology company working on cancer

Related Keywords

United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,Nicoletta Eliopoulos ,Sebastien Plouffe ,Defence Therapeutics Inc ,British Columbia Newsfile Corp ,Lady Davis Institute ,Laboratory Annex ,Jewish General Hospital ,Clean Room ,Defence Therapeutics ,Statement Regarding ,Defence ,Herapeutics ,Dancer ,Vaccine ,Ccuvac ,001 ,Manufacturing ,Targets ,Melanoma ,Breast ,